Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic Effect on ANI-Guided Remifentanil
NCT06015711Recruiting
- Sponsor
- Ajou University School of Medicine
- Start
- Aug 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetaminophen + ibuprofen in pain (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Remifentanil requirement at 3 hours. Started Aug 2023; status: recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT06015711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015711.